Evidence map›Paper›PMID 28386724›Full record

ReviewCellular and molecular life sciences : CMLS2017

Shaping the cellular landscape with Set2/SETD2 methylation.

Stephen L McDaniel, Brian D Strahl

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Epigenetics in the modern era of crop improvements.Science China. Life sciences · 2025
    Review
  10. Chromatin modifiers in neurodevelopment.Frontiers in molecular neuroscience · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  17. DNA Repair in Nucleosomes: Insights from Histone Modifications and Mutants.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Stephen L McDanielDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, WI, 53706, USA.
Brian D StrahlCurriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill, NC, 27599, USA. brian_strahl@med.unc.edu.ORCID 0000-0002-4947-6259
University of North Carolina at Chapel Hill · USUniversity of Wisconsin–Madison · US

Funding

Role of Set2 and H3 methylation in chromatin functionR01GM068088 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STRAHL, BRIAN D · 2003 to 2017
$3.4M
Chromatin maintenance in cancer progressionR01CA198482 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DAVIS, IAN J, RATHMELL, WENDY KIMRYN · 2015 to 2019
$2.3M
Factors that regulate chromatin organization and gene transcriptionR01GM110058 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STRAHL, BRIAN D · 2014 to 2017
$1.2M
NCI NIH HHS R01 CA198482NIGMS NIH HHS R01 GM068088NIGMS NIH HHS R01 GM110058
6 · The paper itself

Abstract

Chromatin structure is a major barrier to gene transcription that must be disrupted and re-set during each round of transcription. Central to this process is the Set2/SETD2 methyltransferase that mediates co-transcriptional methylation to histone H3 at lysine 36 (H3K36me). Studies reveal that H3K36me not only prevents inappropriate transcriptional initiation from arising within gene bodies, but that it has other conserved functions that include the repair of damaged DNA and regulation of pre-mRNA splicing. Consistent with the importance of Set2/SETD2 in chromatin biology, mutations of SETD2, or mutations at or near H3K36 in H3.3, have recently been found to underlie cancer development. This review will summarize the latest insights into the functions of Set2/SETD2 in genome regulation and cancer development.

Indexed as

AnimalsChromatinDNA RepairHistone ChaperonesHistone-Lysine N-MethyltransferaseHistonesHumansMethylationProtein DomainsTranscription, GeneticYeastsChromatinHistone ChaperonesHistone-Lysine N-MethyltransferaseHistonesSETD2 protein, humanCryptic transcriptionH3K36 methylationHistoneSet2SETD2Transcriptional regulation

Identifiers

PMID28386724
PMCPMC5545052
OpenAlexW2604645699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.